Thermo Fisher to Expand its Clinical Trials Capabilities and Collaborates with Frontier to Develop Therapy for HIV

Shots:

• Thermo Fisher expands its clinical trials supply and distribution services network in China with the investment of $4.4M in its Suzhou facility to support the growth of clinical studies and to provide biotech companies with the resources to develop and commercialize new therapies in China
• Additionally, Thermo Fisher collaborates with Frontier to expedite the commercialization of 3BNC117 and will be the exclusive manufacturing partner of 3BNC117 to support pivotal study, PPQ & global commercial supply by manufacturing it in its St. Louis facility
• The new clinical trial facility adds 10°C-20°C beta-lactam storage, cold chain capacity, and increases current storage capacity for temperatures at 15°C to 25°C, 2°C to 8°C and -20°C making it Thermo Fisher’s largest clinical trial facility in Suzhou
  

Click here to­ read full press release/ article | Ref: Thermo Fisher | Image: BioTecNika